**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 7550-35-8 |Lithium Bromide | 99+ | 231-439-8 |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: XN
Risk Phrases: 22
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Harmful if swallowed.Hygroscopic (absorbs moisture from the air).
Potential Health Effects
Eye:
Causes eye irritation and possible burns.
Skin:
Chronic ingestion may cause dizziness, ringing in the ears, visual
disturbances, tremors, and mental confusion. Exposure to bromides may
cause rashes, especially of the face (resembling acne) and boils.
Anhydrous lithium bromide is extremely hygroscopic and contact with
tissue can produce a dehydrating action resulting in localized burns.
Ingestion:
May cause central nervous system depression. May cause disturbed
blood electrolyte balance. Causes gastrointestinal tract irritation.
Large doses of lithium may cause dizziness, prostration, and kidney
damage. Dehydration, weight loss, slurred speech, blurred vision,
sensory loss, ataxia (failure of muscular coordination), tremors, and
convulsions may occur. May be harmful if swallowed. May produce
depression, emaciation with severe cases resulting in pyschosis and
mental deterioration.
Inhalation:
May cause severe irritation of the upper respiratory tract with
pain, burns, and inflammation.
Chronic:
Chronic ingestion may cause dizziness, ringing in the ears, visual
disturbances, tremors, and mental confusion. Prolonged absorption may
affect electrolyte balance and impair kidney function. Dehydration,
weight loss, skin effects, and thyroid disturbances have been
reported. Chronic exposure may cause kidney damage.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Immediately flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid
immediately.
Skin:
Get medical aid immediately. Immediately flush skin with plenty of
water for at least 15 minutes while removing contaminated clothing
and shoes. Wash clothing before reuse.
Ingestion:
Do not induce vomiting. If victim is conscious and alert, give 2-4
cupfuls of milk or water. Never give anything by mouth to an
unconscious person. Get medical aid immediately.
Inhalation:
Get medical aid immediately. Remove from exposure and move to fresh
air immediately. If breathing is difficult, give oxygen. Do NOT use
mouth-to-mouth resuscitation. If breathing has ceased apply
artificial respiration using oxygen and a suitable mechanical device
such as a bag and a mask.
Notes to Physician:
Treat symptomatically and supportively.
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. During a fire, irritating and highly toxic gases
may be generated by thermal decomposition or combustion. This
material in sufficient quantity and reduced particle size is capable
of creating a dust explosion.
Extinguishing Media:
Use extinguishing media most appropriate for the surrounding fire.
Cool containers with flooding quantities of water until well after
fire is out. Use water spray, dry chemical, carbon dioxide, or
appropriate foam.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal
container. Clean up spills immediately, observing precautions in the
Protective Equipment section. Avoid generating dusty conditions.
Provide ventilation.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Wash hands before eating. Remove
contaminated clothing and wash before reuse. Use only in a
well-ventilated area. Minimize dust generation and accumulation. Do
not breathe dust, vapor, mist, or gas. Do not get in eyes, on skin,
or on clothing. Keep container tightly closed. Do not ingest or
inhale.
Storage:
Store in a tightly closed container. Store in a cool, dry,
well-ventilated area away from incompatible substances. Store
protected from moisture.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use adequate
ventilation to keep airborne concentrations low.
Exposure Limits
CAS# 7550-35-8:
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
A respiratory protection program that meets OSHA's 29
CFR 1910.134 and ANSI Z88.2 requirements or European
Standard EN 149 must be followed whenever workplace
conditions warrant respirator use.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Powder
Color: white
Odor: none reported
pH: Neutral/Alkaline
Vapor Pressure: 1.0 mm Hg @ 748 deg C
Viscosity: Not applicable.
Boiling Point: 1265 deg C
Freezing/Melting Point: 547 deg C
Autoignition Temperature: Not applicable.
Flash Point: Not applicable.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature: Not available.
Solubility in water: Soluble.
Specific Gravity/Density: 3.464 @ 35C
Molecular Formula: LiBr
Molecular Weight: 86.845
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Incompatible materials, dust generation, moisture, excess heat,
exposure to moist air or water.
Incompatibilities with Other Materials:
Moisture, strong oxidizing agents, strong acids.
Hazardous Decomposition Products:
Irritating and toxic fumes and gases, hydrogen bromide, oxides of
lithium.
Hazardous Polymerization: Will not occur.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 7550-35-8: OJ5755000
LD50/LC50:
CAS# 7550-35-8: Oral, mouse: LD50 = 1840 mg/kg; Oral, mouse: LD50 =
2353 mg/kg; Oral, rat: LD50 = 1800 mg/kg.
Oral, rat: LD50 = 1800
Carcinogenicity:
Lithium Bromide -
Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN
Risk Phrases:
R 22 Harmful if swallowed.
Safety Phrases:
WGK (Water Danger/Protection)
CAS# 7550-35-8: 1
Canada
CAS# 7550-35-8 is listed on Canada's DSL List.
CAS# 7550-35-8 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 7550-35-8 is listed on the TSCA inventory.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 6/29/1999 Revision #2 Date: 3/18/2003
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
Lanthanum(III) nitrate hexahydrate, 99.999%
| 10099-59-9 |
|
Methyl vinyl ketone, ca. 95%, stabilized with ca. 0.5% CH3CN, 0.5%
| 64-19-7 |
|
Lead, Powder, -325 Mesh, 99+%
| 7439-92-1 |
|
Triethoxyvinylsilane, 97%
| 78-08-0 |
|
2-Methylhexanoic Acid, 98%
| 4536-23-6 |
|
Lead(II) Acetate Trihydrate, P.A.
| 6080-56-4 |
|
1-Dodecanethiol
| 112-55-0 |
|
Lead (II) Nitrate, P.A.
| 10099-74-8 |
|
Lead subacetate, basic, reagent ACS, powder (for sugar analysis)
| 1335-32-6 |
|
Tetrabutylammonium perchlorate, contains max. 10% water, 99%
| 1923-70-2 |
|
3-Methyl-4-Nitrobenzyl Alcohol , 98%
| 80866-75-7 |
|
Light Green SF, Yellowish, High Purity Biological Stain
| 5141-20-8 |
|
Petroleum Ether, Boiling Range 40-65 Degr. C., P.A.
| 8032-32-4 |
|
Ligroine
| 8032-32-4 |
|
Ligroine, boiling range 90 - 110 degree C
| 8032-32-4 |
|
Petroleum Ether, Reagent ACS
| 8032-32-4 |
|
Petroleum Ether, Boiling Range 40-65 Degree C, C.P.
| 8032-32-4 |
|
Ligroine, boiling point 100-140 degree C
| 8032-32-4 |
|
Petroleum Ether, Boiling Range 80-110 Degree C, P.A.
| 8032-32-4 |
|
Petroleum Ether (Boiling Range 60-95), C.P.
| 8032-32-4 |
|
1,5-Hexadiene, 98%
| 592-42-7 |
|
Chloroiodomethane, 98%
| 593-71-5 |
|
Lithium Bromide, Anhydrous, 99+%
| 7550-35-8 |
|
Lithium Carbonate, 99.999%
| 554-13-2 |
|
Lithium Carbonate, Reagent ACS (Powder), 99+% (Titr.)
| 554-13-2 |
|
Lithium Chloride, Anhydrous, 99%
| 7447-41-8 |
|
Lithium Fluoride, 99.98%
| 7789-24-4 |
|
Thiophenol, 97%
| 108-98-5 |
|
2-Chloropropane, 96%
| 75-29-6 |
|
Magnesium, turnings, 99.9+%
| 7439-95-4 |
|
Magnesium Acetate Tetrahydrate, Pure, Crystalline
| 16674-78-5 |
|
Magnesium Acetate Tetrahydrate, Reagent ACS (Crystals)
| 16674-78-5 |
|
Magnesium Chloride Hexahydrate, 99%
| 7791-18-6 |
|
Wright stain, high purity biological stain
| 67-56-1 |
|
Magnesium Chloride, Hexahydrate, U.S.P./ N.F. (Crystals)
| 7791-18-6 |
|
1-Bromooctane, 99%
| 111-83-1 |
|
4-Chloropyridine Hydrochloride, 97%
| 7379-35-3 |
|
Magnesium nitrate hexahydrate p.a.
| 13446-18-9 |
|
Magnesium Oxide, 98% (CA 40 Mesh)
| 1309-48-4 |
|
Magnesium Oxide, 98%, Powder
| 1309-48-4 |
|
Magnesium Oxide, Reagent ACS (Powder)
| 1309-48-4 |
|
Magnesium Oxide, 99.99%
| 1309-48-4 |
|
Magnesium Sulfate, Dried, Pure
| 7487-88-9 |
|
2-Chloro-4-hydroxybenzoic acid,98% (titr.)
| 56363-84-9 |
|
Guanidine carbonate, 99+%
| 593-85-1 |
|
Magnesium sulfate heptahydrate, C.P.
| 7487-88-9 |
|
Magnesium sulfate heptahydrate, Reagent ACS (Crystals)
| 7487-88-9 |
|
2-Aminobenzimidazole, 99+% (titr.)
| 934-32-7 |
|
Manganese(IV) Oxide, 99.999%
| 1313-13-9 |
|
Manganese(IV) Oxide, 80-85%, Powder
| 1313-13-9 |
|
|